EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

(5S)-5-[(2-(5-Bromo-2-methoxyphenyl)quinazolin-4-yl Amino)methyl]-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one

Mingguang Zhang, Siyu Hao, Baiyang Mao, Yongxu Piao

Molbank · 10.07.2026 · 2026 (4) · M2202

DOI: 10.3390/m2202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molbank, online erschienen am 10.07.2026. Verfasst von Mingguang Zhang und 3 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Project of Yancheng Health Commission, Jiangsu Vocational College of Medicine.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

4-aminoquinazoline derivatives exhibit unique physiological activities, including antitumor, anti-inflammatory, and antibacterial biological activities. Afatinib (BIBW-2992), the representative tyrosine kinase inhibitor, has been developed for the treatment of non-small cell lung cancer. Following our expanded medical chemistry research program, we report a novel 4-aminoquinazoline derivative named JSLN-P (1), (5S)-5-[(2-(5-bromo-2-methoxyphenyl) quinazolin-4-ylamino)methyl]-3-(3-fluoro-4-morpholino phenyl) oxazolidin-2-one, aimed for developing new drugs with antiglioma properties. The title compound JSLN-P (1) was successfully synthesized by amination approaches following benzylamination and oxazolone cyclization, further condensation with 4-(4-bromo-2-fluorophenyl) morpholine, reduction in debenzylation and halogenated amination of quinazolin. The structure of JSLN-P (1) was confirmed by 1H and 13C nuclear magnetic resonance (NMR) and high-resolution mass spectrometry (HRMS).

Förderung

  • Medical Research Project of Yancheng Health Commission
  • Jiangsu Vocational College of Medicine

Zitieren

APA

Zhang, M., Hao, S., Mao, B., & Piao, Y. (2026). (5S)-5-[(2-(5-Bromo-2-methoxyphenyl)quinazolin-4-yl Amino)methyl]-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one. Molbank, 2026(4), M2202. https://doi.org/10.3390/m2202

Vancouver

Zhang M, Hao S, Mao B, Piao Y. (5S)-5-[(2-(5-Bromo-2-methoxyphenyl)quinazolin-4-yl Amino)methyl]-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one. Molbank. 2026;2026(4):M2202. doi:10.3390/m2202

BibTeX
@article{Zhang2026,
  author = {Zhang, Mingguang and Hao, Siyu and Mao, Baiyang and Piao, Yongxu},
  title = {(5S)-5-[(2-(5-Bromo-2-methoxyphenyl)quinazolin-4-yl Amino)methyl]-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one},
  journal = {Molbank},
  year = {2026},
  volume = {2026},
  number = {4},
  pages = {M2202},
  doi = {10.3390/m2202}
}
Kostenlos starten →